e-learning
resources
Barcelona 2010
Monday, 20.09.2010
Tuberculosis: metabolic insights
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Does diabetes mellitus affect T-cell interferon-gamma responses in TB patients?
S. H. Gan, K. W. KhinMar, T. Barkham, C. K. Koh, Y. T. Wang, C. B. E. Chee (Singapore, Singapore)
Source:
Annual Congress 2010 - Tuberculosis: metabolic insights
Session:
Tuberculosis: metabolic insights
Session type:
Thematic Poster Session
Number:
3038
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. H. Gan, K. W. KhinMar, T. Barkham, C. K. Koh, Y. T. Wang, C. B. E. Chee (Singapore, Singapore). Does diabetes mellitus affect T-cell interferon-gamma responses in TB patients?. Eur Respir J 2010; 36: Suppl. 54, 3038
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Related content which might interest you:
Interferon-? responses to Mycobacterium tuberculosis-specific antigens in diabetes mellitus
Source: Eur Respir J 2014; 44: 805-808
Year: 2014
Presentations and treatment response of pulmonary tuberculosis in type 2 diabetes mellitus
Source: Annual Congress 2012 - Tuberculosis: clinical findings II
Year: 2012
Is there any characteristics difference between pulmonary tuberculosis patients with and without diabetes mellitus type 2?
Source: Annual Congress 2009 - Tuberculosis: metabolism and comorbidities
Year: 2009
?cute phase proteins in patients with pulmonary tuberculosis combined with diabetes mellitus.
Source: International Congress 2017 – Human susceptibility to tuberculosis
Year: 2017
Prevalence of atopy and respiratory symptoms in type 1 diabetes mellitus (T1DM) patients
Source: Annual Congress 2005 - Environmental factors, allergy and asthma
Year: 2005
Newly detected pulmonary tuberculosis in patients combined with diabetes mellitus and without it.
Source: International Congress 2019 – Tuberculosis and comorbidities
Year: 2019
Mesodiencephalic modulation in the treatment of XDR TB patients with concomitant type II diabetes mellitus
Source: Virtual Congress 2021 – Tuberculosis, COVID-19 and other comorbidities
Year: 2021
Treatment effectiveness among patients with newly detected pulmonary tuberculosis with diabetes mellitus comorbidity
Source: Eur Respir J 2004; 24: Suppl. 48, 653s
Year: 2004
Metformin predispose acute exacerbations of COPD patients with insulin-dependent diabetes mellitus>
Source: International Congress 2018 – COPD and extrapulmonary comorbidities
Year: 2018
Inhaled insulin does not induce immediate airway responsiveness in patients with type 1 diabetes mellitus
Source: Eur Respir J 2005; 26: Suppl. 49, 582s
Year: 2005
Role of BMI in the clinical course of COPD patients with type 2 diabetes mellitus
Source: International Congress 2018 – COPD and extrapulmonary comorbidities
Year: 2018
Effectiveness of mesodiencephalic modulation in treatment of XDR TB patients with concomitant type II diabetes mellitus
Source: International Congress 2019 – Extra-pulmonary tuberculosis and comorbidities
Year: 2019
Risk of development of diabetes mellitus in patients with bronchial asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 323s
Year: 2006
Prevalence and factors associated with diabetes mellitus among tuberculosis patients: a nationwide cohort
Source: Eur Respir J 2016; 48: 264-268
Year: 2016
Comparison of COPD patients with and without diabetes mellitus
Source: Virtual Congress 2020 – Diagnosis and management of COPD
Year: 2020
Adverse events in the treatment of patients with pulmonary tuberculosis combined with diabetes mellitus and without it.
Source: Virtual Congress 2021 – Tuberculosis, COVID-19 and other comorbidities
Year: 2021
Clinical features of pulmonary tuberculosis in patients with diabetes mellitus
Source: Annual Congress 2012 - Tuberculosis: clinical findings III
Year: 2012
Development of diabetes mellitus in patients with bronchial asthma
Source: Annual Congress 2008 - Novel experimental approaches to understanding asthma and COPD II
Year: 2008
Impact of diabetes mellitus on pulmonary tuberculosis clinical presentation and treatment outcomes
Source: International Congress 2018 – Tuberculosis comorbidities
Year: 2018
Importance of hereditary predisposition factors in patients with tuberculosis combined with diabetes mellitus
Source: Eur Respir J 2002; 20: Suppl. 38, 556s
Year: 2002
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept